Lemaitre Vascular (LMAT) Capital Expenditures (2010 - 2026)

Lemaitre Vascular (LMAT) has 17 years of Capital Expenditures data on file, last reported at $2.8 million in Q1 2026.

• Capital Expenditures for Q1 2026 came in at $2.8 million, up 101.23% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.2 million (up 17.32% YoY), and the FY2025 annual result was $6.8 million, down 2.57% from the prior year.
• Capital Expenditures improved to $2.8 million in Q1 2026 per LMAT's latest filing, from $1.8 million in the prior quarter.
• Over five years, Capital Expenditures peaked at $2.8 million in Q2 2023 and troughed at $460000.0 in Q3 2022.
• A 5-year average of $1.6 million and a median of $1.4 million in 2025 frame the typical range for Capital Expenditures.
• The sharpest annual moves came in 2022 and 2023: Capital Expenditures plunged 74.64% in 2022, then soared 297.39% in 2023.
• A 5-year view of Capital Expenditures shows it stood at $1.3 million in 2022, then increased by 1.51% to $1.3 million in 2023, then jumped by 59.81% to $2.0 million in 2024, then slipped by 13.06% to $1.8 million in 2025, then soared by 56.61% to $2.8 million in 2026.
• Business Quant data shows LMAT's Capital Expenditures at $2.8 million in Q1 2026, $1.8 million in Q4 2025, and $2.3 million in Q3 2025.